Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
CareDx, Inc

CareDx, Inc (CDNA) Stock Overview

Explore CareDx, Inc’s financial performance, market position, analyst ratings, and future outlook.

CDNA●NASDAQ
HealthcareMedical - Diagnostics & Research
$45.50
$1.59(3.38%)
U.S. Market opens in 12h 46m

CareDx, Inc (CDNA)

Meyka AI Score

Z

Key Financials

Market Cap2.4B
P/E Ratio21.33
EPS (TTM)$0.84
ROE0.33%
Fundamental Analysis

AI Price Forecasts

1 Month$45.46
3 Months$30.08
1 Year Target$25.89

CDNA Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of CareDx, Inc (NASDAQ: CDNA) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, CareDx, Inc's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of CDNA on the NASDAQ shows an RSI of 73.21, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $25.89 for the NASDAQ listing.

Key metrics behind CareDx, Inc's NASDAQ-traded stock include a P/E ratio of 21.33 and a market capitalization of 2.4B. Combined with our AI analysis, these give both institutional and retail investors a clear view of CDNA on the NASDAQ.

Price Performance (NASDAQ: CDNA)

1-Day Change
-3.38%
5-Day Change
7.08%
1-Month Change
56.57%
3-Month Change
119.81%
6-Month Change
147.96%
Year-to-Date (YTD) Change
141.51%
1-Year Change
254.09%
3-Year Change
321.30%
5-Year Change
-46.08%
All-Time (Max) Change
402.76%

Contact Information

https://www.caredx.com
415 287 2300
8000 Marina Boulevard, Brisbane, CA, 94080

Company Facts

7,650 Employees
IPO DateJul 17, 2014
CountryUS
Actively Trading

Frequently Asked Questions